APC Anti-Human CD56 Antibody[MEM188]

Introducing the APC Anti-Human CD56 Antibody [MEM188], a highly reliable and efficient solution for immunohistochemistry and flow cytometry applications. This product, available in a convenient size of 50 tests, is designed to facilitate accurate and precise identification of CD56 antigen expression in human samples.

Crafted with utmost precision and utilizing advanced technology, our APC Anti-Human CD56 Antibody [MEM188] offers exceptional specificity and sensitivity. This antibody is specifically engineered to target CD56, a cell surface glycoprotein predominantly expressed on natural killer cells and neural tissues. By selectively binding to CD56, this antibody enables researchers and clinicians to discern and analyze the distribution and abundance of CD56-positive cells with utmost confidence.

The APC Anti-Human CD56 Antibody [MEM188] is meticulously manufactured to ensure consistent and reproducible results. Its exceptional performance is attributed to its high affinity and low background, allowing for accurate and reliable detection of CD56 antigen expression. This antibody is optimized for use in various experimental settings, including immunohistochemistry and flow cytometry, making it a versatile tool for a wide range of research and diagnostic applications.

Furthermore, the APC Anti-Human CD56 Antibody [MEM188] is designed to provide convenience and ease of use. Its ready-to-use format eliminates the need for time-consuming and complex preparation steps, enabling researchers to save valuable time and resources. Additionally, this antibody is compatible with a variety of sample types, including formalin-fixed paraffin-embedded tissues and fresh or frozen specimens, ensuring its adaptability to diverse experimental requirements.

In summary, the APC Anti-Human CD56 Antibody [MEM188] is a highly reliable and efficient tool for the accurate detection and analysis of CD56 antigen expression in human samples. With its exceptional specificity, sensitivity, and convenience, this antibody is an invaluable asset for researchers and clinicians alike, facilitating groundbreaking discoveries and advancements in the field of immunology and beyond.